Journal articles on the topic 'Hepatitis B cor'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Hepatitis B cor.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Maria, Rafael Carvalho de, Joseneide Teixeira Câmara, Maria Edileuza Soares Moura, Felipe Santana e. Silva, and Josemeire da Costa Ximenes. "Analysis of space and epidemiological distribution of hepatitis b and c cases in municipaly maranhão / Análise da distribuição espacial e epidemiológica dos casos de hepatite b e c em município maranhense." Revista de Pesquisa Cuidado é Fundamental Online 13 (September 22, 2021): 1421–27. http://dx.doi.org/10.9789/2175-5361.rpcfo.v13.9702.
Full textPolish, L. B., M. Gallagher, H. A. Fields, and S. C. Hadler. "Delta hepatitis: molecular biology and clinical and epidemiological features." Clinical Microbiology Reviews 6, no. 3 (July 1993): 211–29. http://dx.doi.org/10.1128/cmr.6.3.211.
Full textToy, Mehlika, Samuel So, and David W. Hutton. "Hepatitis B cure." Current Opinion in HIV and AIDS 15, no. 3 (May 2020): 208–12. http://dx.doi.org/10.1097/coh.0000000000000617.
Full textValsamakis, Alexandra. "Molecular Testing in the Diagnosis and Management of Chronic Hepatitis B." Clinical Microbiology Reviews 20, no. 3 (July 2007): 426–39. http://dx.doi.org/10.1128/cmr.00009-07.
Full textMahoney, Francis J. "Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection." Clinical Microbiology Reviews 12, no. 2 (April 1, 1999): 351–66. http://dx.doi.org/10.1128/cmr.12.2.351.
Full textFeitelson, M. "Hepatitis B virus infection and primary hepatocellular carcinoma." Clinical Microbiology Reviews 5, no. 3 (July 1992): 275–301. http://dx.doi.org/10.1128/cmr.5.3.275.
Full textAudsley, Jennifer, and Joe Sasadeusz. "Challenges and opportunities for hepatitis B cure in the setting of HIV--hepatitis B virus co-infection." Current Opinion in HIV and AIDS 15, no. 3 (May 2020): 193–99. http://dx.doi.org/10.1097/coh.0000000000000624.
Full textSugarman, Jeremy. "Ethics of HIV and hepatitis B cure research." Current Opinion in HIV and AIDS 15, no. 3 (May 2020): 180–84. http://dx.doi.org/10.1097/coh.0000000000000618.
Full textZhou, Xiaojing, Hongfei Wei, Peng Sun, Xiuli Wu, Min Wan, Peng Zhang, Sheng Guo, Tiesuo Zhao, Yongli Yu, and Liying Wang. "Recombinant Hepatitis B Virus Surface Antigen Formulated with B-Type CpG Oligodeoxynucleotide Induces Therapeutic Immunity Against Hepatitis B Virus Surface Antigen-Expressing Liver Cancer Cells in Mice." Cancer Biotherapy and Radiopharmaceuticals 27, no. 4 (May 2012): 234–42. http://dx.doi.org/10.1089/cbr.2011.1127.
Full textMaini, Mala K., and Dimitra Peppa. "Shared immunotherapeutic approaches in HIV and hepatitis B virus." Current Opinion in HIV and AIDS 15, no. 3 (May 2020): 157–64. http://dx.doi.org/10.1097/coh.0000000000000621.
Full textSbarigia, Urbano, Talitha Vincken, Peter Wigfield, Mahmoud Hashim, Bart Heeg, and Maarten Postma. "A comparative network meta-analysis of standard of care treatments in treatment-naïve chronic hepatitis B patients." Journal of Comparative Effectiveness Research 9, no. 15 (October 2020): 1051–65. http://dx.doi.org/10.2217/cer-2020-0068.
Full textSamal, J., M. Kandpal, and P. Vivekanandan. "Molecular Mechanisms Underlying Occult Hepatitis B Virus Infection." Clinical Microbiology Reviews 25, no. 1 (January 1, 2012): 142–63. http://dx.doi.org/10.1128/cmr.00018-11.
Full textFeitelson, M. "Hepatitis B virus infection and primary hepatocellular carcinoma." Clinical Microbiology Reviews 5, no. 3 (1992): 275–301. http://dx.doi.org/10.1128/cmr.5.3.275-301.1992.
Full textHou, Jinlin, Wendong Chen, Ying Han, Lei Wang, I.-Heng Lee, Ling-I. Hsu, Dongying Xie, Xueru Yin, Fengqin Hou, and Yida Yang. "Shifting demographics and comorbidity burden in adult Chinese urban patients with chronic hepatitis B, 2013 and 2016." Journal of Comparative Effectiveness Research 10, no. 8 (June 2021): 647–57. http://dx.doi.org/10.2217/cer-2020-0080.
Full textAbdel-Rahman, Omar. "Patterns and association of vaccination among adults with a history of cancer in the USA: a population-based study." Journal of Comparative Effectiveness Research 10, no. 11 (August 2021): 899–907. http://dx.doi.org/10.2217/cer-2020-0251.
Full textAllweiss, Lena, and Helene Strick-Marchand. "In-vitro and in-vivo models for hepatitis B cure research." Current Opinion in HIV and AIDS 15, no. 3 (May 2020): 173–79. http://dx.doi.org/10.1097/coh.0000000000000616.
Full textFrench, Janine, Stephen Locarnini, and Fabien Zoulim. "Direct-acting antivirals and viral RNA targeting for hepatitis B cure." Current Opinion in HIV and AIDS 15, no. 3 (May 2020): 165–72. http://dx.doi.org/10.1097/coh.0000000000000622.
Full textdo Monte, Larissa Emilly Fiusa, Vanessa Ferreira Barroso, Isabela Coelho Simão, Karyne Costa Cavalcante, Claudio Vinicius Araujo Pinheiro, Viviane Melo e. Silva de Figueiredo, Juliana Ramos Carneiro, and Plínio da Cunha Leal. "ASSOCIATION BETWEEN HEPATITIS B AND C WITH HEPATOCELLULAR CARCINOMA: A LITERATURE REVIEW." Revista UNINGÁ 58 (March 11, 2021): eUJ3954-eUJ3954. http://dx.doi.org/10.46311/2318-0579.58.euj3954.
Full textLiu, Wei, Rui Lv, Wenyang Huang, Hong Liu, Shuhui Deng, Shuhua Yi, Lulu Lv, Jianxiang Wang, Lugui Qiu, and Dehui Zou. "The Risk of Hepatitis B Reactivation Is Controllable in Patients with Concomitant Hepatitis B Virus Infection during Chimeric Antigen Receptor T-Cell Therapy." Blood 134, Supplement_1 (November 13, 2019): 2913. http://dx.doi.org/10.1182/blood-2019-126635.
Full textWagner, S. J., L. I. Friedman, and R. Y. Dodd. "Transfusion-associated bacterial sepsis." Clinical Microbiology Reviews 7, no. 3 (July 1994): 290–302. http://dx.doi.org/10.1128/cmr.7.3.290.
Full textDennehy, Penelope H. "Active Immunization in the United States: Developments over the Past Decade." Clinical Microbiology Reviews 14, no. 4 (October 1, 2001): 872–908. http://dx.doi.org/10.1128/cmr.14.4.872-908.2001.
Full textBansal, Radhika, Paschalis Vergidis, Pritish Tosh, John W. Wilson, Matthew Hathcock, N. Nora Bennani, Jonas Paludo, et al. "Vaccine titers in lymphoma patients receiving chimeric antigen receptor T-cell therapy." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 7555. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.7555.
Full textKeller, Margaret A., and E. Richard Stiehm. "Passive Immunity in Prevention and Treatment of Infectious Diseases." Clinical Microbiology Reviews 13, no. 4 (October 1, 2000): 602–14. http://dx.doi.org/10.1128/cmr.13.4.602.
Full textTatsuno, Kenji, Yutaka Midorikawa, Tadatoshi Takayama, Shogo Yamamoto, Genta Nagae, Mitsuhiko Moriyama, Hayato Nakagawa, Kazuhiko Koike, Kyoji Moriya, and Hiroyuki Aburatani. "Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection." Clinical Cancer Research 25, no. 20 (July 18, 2019): 6217–27. http://dx.doi.org/10.1158/1078-0432.ccr-18-4041.
Full textHan, Lu, Jian Zhou, Keshu Zhou, Xinghu Zhu, Lingdi Zhao, Baijun Fang, Qingsong Yin, et al. "Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus." Journal for ImmunoTherapy of Cancer 8, no. 2 (August 2020): e000927. http://dx.doi.org/10.1136/jitc-2020-000927.
Full textDe Clercq, Erik. "Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections." Clinical Microbiology Reviews 16, no. 4 (October 2003): 569–96. http://dx.doi.org/10.1128/cmr.16.4.569-596.2003.
Full textHulstaert, Eva, Xavier Verhelst, Anja Geerts, and Hans Van Vlierberghe. "Intramuscular hepatitis B immunoglobulins for reinfection control after liver transplantation: a cost-saving alternative." Journal of Comparative Effectiveness Research 4, no. 3 (May 2015): 259–65. http://dx.doi.org/10.2217/cer.15.4.
Full textKramvis, Anna. "Challenges for hepatitis B virus cure in resource-limited settings in sub-Saharan Africa." Current Opinion in HIV and AIDS 15, no. 3 (May 2020): 185–92. http://dx.doi.org/10.1097/coh.0000000000000619.
Full textMaepa, Mohube B., Ridhwaanah Jacobs, Fiona van den Berg, and Patrick Arbuthnot. "Recent developments with advancing gene therapy to treat chronic infection with hepatitis B virus." Current Opinion in HIV and AIDS 15, no. 3 (May 2020): 200–207. http://dx.doi.org/10.1097/coh.0000000000000623.
Full textCalvo Bernal, MM, MM Moya Montoya, N. Campos Serrano, AP Jácome Pérez, A. Aparicio Mota, A. de Vicente Ortega, and M. Casado Martín. "Hepatitis B, C, HIV infection and liver disease in patients with SARS-CoV-2 infection. Clinical implications." Revista Andaluza de Patología Digestiva 45, no. 5 (January 5, 2023): 535–40. http://dx.doi.org/10.37352/2022456.1.
Full textBlair, D. C. "A week in the life of a travel clinic." Clinical Microbiology Reviews 10, no. 4 (October 1997): 650–73. http://dx.doi.org/10.1128/cmr.10.4.650.
Full textLuz, Dinah Lopes Marques, Bruna Letícia Gomes Costa Wanderley, Antonio Fernando Silva Xavier Júnior, and Laércio Pol-Fachin. "Perfil epidemiológico das hepatites B e C em Maceió-AL no período de 2010-2020." Revista Eletrônica Acervo Saúde 13, no. 11 (November 17, 2021): e9200. http://dx.doi.org/10.25248/reas.e9200.2021.
Full textYeo, Winnie, Edwin P. Hui, Anthony T. C. Chan, Wing M. Ho, Kwok C. Lam, Paul K. S. Chan, Tony S. K. Mok, Jam J. Lee, Frankie K. F. Mo, and Philip J. Johnson. "Prevention of Hepatitis B Virus Reactivation in Patients With Nasopharyngeal Carcinoma With Lamivudine." American Journal of Clinical Oncology 28, no. 4 (August 2005): 379–84. http://dx.doi.org/10.1097/01.coc.0000159554.97885.88.
Full textBansal, Radhika, Paschalis Vergidis, Pritish K. Tosh, John Wilson, Matthew Hathcock, Arushi Khurana, N. Nora Bennani, et al. "Vaccine Titers in Lymphoma Patients Receiving Chimeric Antigen Receptor T Cell Therapy." Blood 138, Supplement 1 (November 5, 2021): 3857. http://dx.doi.org/10.1182/blood-2021-153500.
Full textHuang, Jian, Fu-Chen Liu, Li Li, Sheng-Xian Yuan, Yuan Yang, Bei-Ge Jiang, Hui Liu, and Ze-Ya Pan. "Prognostic Nomogram for Hepatitis B Virus–related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection." American Journal of Clinical Oncology 43, no. 1 (January 2020): 20–27. http://dx.doi.org/10.1097/coc.0000000000000619.
Full textBeltrami, Elise M., Ian T. Williams, Craig N. Shapiro, and Mary E. Chamberland. "Risk and Management of Blood-Borne Infections in Health Care Workers." Clinical Microbiology Reviews 13, no. 3 (July 1, 2000): 385–407. http://dx.doi.org/10.1128/cmr.13.3.385.
Full textMoon, Yuseok, Seok Goo Cho, Jong Wook Lee, Woo Sung Min, Chun Choo Kim, Hae-Kyung Lee, Yong-Goo Kim, et al. "Protective Effect of Irradiated Renal Carcinoma Expressing Hepatitis B Surface Antigen Against Renal-Cell Carcinoma–Mediated Tumors." Cancer Biotherapy and Radiopharmaceuticals 21, no. 3 (June 2006): 211–16. http://dx.doi.org/10.1089/cbr.2006.21.211.
Full textRey, Esther, Patricia Marañón, and Águeda González-Rodríguez. "SOFOSBUVIR TREATMENT IMPROVES HEPATITIS C VIRUS-INDUCED INSULIN RESISTANCE." Anales de la Real Academia Nacional de Farmacia, no. 87(01) (2021): 15–26. http://dx.doi.org/10.53519/analesranf.2021.87.01.01.
Full textTang, Kevin, and Loretta J. Nastoupil. "Real-World Experiences of CAR T-Cell Therapy for Large B-Cell Lymphoma: How Similar Are They to the Prospective Studies?" Journal of Immunotherapy and Precision Oncology 4, no. 3 (August 1, 2021): 150–59. http://dx.doi.org/10.36401/jipo-21-2.
Full textDe Clercq, Erik, and Guangdi Li. "Approved Antiviral Drugs over the Past 50 Years." Clinical Microbiology Reviews 29, no. 3 (June 8, 2016): 695–747. http://dx.doi.org/10.1128/cmr.00102-15.
Full textFang, Yixuan, Boxu Liu, and Wenze Song. "CAR-T Therapy: A Promising Cancer Treatment." Highlights in Science, Engineering and Technology 8 (August 17, 2022): 100–110. http://dx.doi.org/10.54097/hset.v8i.1116.
Full textWoo, Hyun Goo, Eun Sung Park, Jae Hee Cheon, Ju Han Kim, Ju-Seog Lee, Bum Joon Park, Won Kim, et al. "Gene Expression–Based Recurrence Prediction of Hepatitis B Virus–Related Human Hepatocellular Carcinoma." Clinical Cancer Research 14, no. 7 (April 1, 2008): 2056–64. http://dx.doi.org/10.1158/1078-0432.ccr-07-1473.
Full textFeldmann, Georg, Hans Dieter Nischalke, Jacob Nattermann, Brigitte Banas, Thomas Berg, Christian Teschendorf, Wolff Schmiegel, et al. "Induction of Interleukin-6 by Hepatitis C Virus Core Protein in Hepatitis C–Associated Mixed Cryoglobulinemia and B-Cell Non–Hodgkin's Lymphoma." Clinical Cancer Research 12, no. 15 (August 1, 2006): 4491–98. http://dx.doi.org/10.1158/1078-0432.ccr-06-0154.
Full textSleijffers, Annemarie, Johan Garssen, Frank R. Gruijl, Greet J. Boland, Jan Hattum, Willem A. Vloten, and Henk Loveren. "UVB Exposure Impairs Immune Responses After Hepatitis B Vaccination in Two Different Mouse Strains¶." Photochemistry and Photobiology 75, no. 5 (May 2002): 541–46. http://dx.doi.org/10.1562/0031-8655(2002)0750541ueiira2.0.co2.
Full textTamori, Akihiro, Yoshihiro Yamanishi, Shuichi Kawashima, Minoru Kanehisa, Masaru Enomoto, Hiromu Tanaka, Shoji Kubo, Susumu Shiomi, and Shuhei Nishiguchi. "Alteration of Gene Expression in Human Hepatocellular Carcinoma with Integrated Hepatitis B Virus DNA." Clinical Cancer Research 11, no. 16 (August 15, 2005): 5821–26. http://dx.doi.org/10.1158/1078-0432.ccr-04-2055.
Full textCao, Wenyue, Jia Wei, Na Wang, Hao Xu, Min Xiao, Lifang Huang, Yang Cao, et al. "Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy." Blood 136, no. 4 (July 23, 2020): 516–19. http://dx.doi.org/10.1182/blood.2020004907.
Full textSleijffers, Annemarie, Arthur Kammeyer, Frank R. Gruijl, Greet J. Boland, Jan Hattum, Willem A. Vloten, Henk Loveren, Marcel B. M. Teunissen, and Johan Garssen. "Epidermal cis-Urocanic Acid Levels Correlate with Lower Specific Cellular Immune Responses After Hepatitis B Vaccination of Ultraviolet B-exposed Humans¶." Photochemistry and Photobiology 77, no. 3 (May 1, 2007): 271–75. http://dx.doi.org/10.1562/0031-8655(2003)0770271ecualc2.0.co2.
Full textPamatika, Christian Maucler, Christian Diamant Mossoro-Kpindé, Aint-Calvaire Henri Dieme, Geoffroy Ndakouzou Kongo, Geoffroy Ndakouzou Kongo, Régina Edwige Lenguetama Kodia, Hyacinthe Nguida, and Jean de Dieu Longo. "Prevalence of chronic viral hepatitis B in Bangui and Bimbo in the Central African Republic: cases of regular voluntary donors not eligible for blood donations." Annales Africaines de Medecine 15, no. 4 (September 23, 2022): e4810-e4817. http://dx.doi.org/10.4314/aamed.v15i4.7.
Full textSamba, D., M. Abdou-Chekaraou, L. Gina, S. Brichler, C. Sholtés, N. Martel, J. O. Ouavéné, et al. "437 ANRS 12202: HEPATITIS B AND DELTA HEPATITIS IN CENTRAL AFRICAN REPUBLIC (CAR): VIROLOGICAL REASSESSMENT OF A FULMINANT HEPATITIS OUTBREAK OCCURRING IN THE MID EIGHTIES." Journal of Hepatology 56 (April 2012): S173—S174. http://dx.doi.org/10.1016/s0168-8278(12)60450-4.
Full textHong, Jisu, Youngjin Choi, Yoonjoo Choi, Jiwoo Lee, and Hyo Jeong Hong. "Epitope–Paratope Interaction of a Neutralizing Human Anti-Hepatitis B Virus PreS1 Antibody That Recognizes the Receptor-Binding Motif." Vaccines 9, no. 7 (July 7, 2021): 754. http://dx.doi.org/10.3390/vaccines9070754.
Full text